摘要
目的:比较2μm激光整块切除与电切治疗非肌层浸润性膀胱癌的有效性及安全性。方法:回顾性分析2015年4月-2017年4月分别采用经尿道2微米激光整块切除(50例)和经尿道电切(48例)治疗非肌层浸润性膀胱癌患者临床随访资料。结果:所有患者手术均顺利完成,激光组与电切组患者手术时间相当,两组比较差异无统计学意义(P>0.05),激光组患者留置尿管、膀胱冲洗及住院时间均少于电切组,比较差异有统计学意义(P<0.05);激光组患者并发症发生率、一年复发率及术区复发率低于电切组,两组比较差异均有统计学意义(P<0.05);激光组术后病理含肌层率高于电切组,两组比较差异有统计学意义(P<0.05)。结论:经尿道2微米激光整块切除治疗非肌层浸润性膀胱癌是一种安全、有效的治疗方式且术后肿瘤分期精确、减少肿瘤残留,是治疗非肌层浸润性膀胱癌较好的手术治疗选择,值得临床上推广应用。
Objective:To compare the efficacy and safety between transurethral en bloc resection of bladder tumor with 2μm laser and traditional transurethral resection of bladder tumor(TURBT)in patients with non-muscle invasive bladder carcinoma(NMIBC).Methods:From April 2015 to April 2017,50 patients underwent transurethral 2μm laser en bloc resection(laser group)and 48 patients underwent traditional transurethral resection(TUR group).Clinical data and follow up were recorded.Results:All operations were successfully performed,and there was no significant difference between two groups in operation time(P>0.05).The length of stay,bladder irrigation time,catheter indwelling time and one-year recurrence rate,operative site recurrence rate,complications rate in the laser group were significantly shorter than in the TUR group and the differences were statistically significant(P<0.05).Complete samples rate in the laser group was higher than that in the TUR group and the difference was statistically significant(P<0.05).Conclusion:Transurethral 2μm laser en bloc resection is a safe and effective for the treatment of non-muscle invasive bladder carcinoma,in addition,it has more advantages in obtaining precise tumor stage,reducing the remnants of the tumor.It is worthy of clinical application.
作者
郭长刚
包国昌
高志明
李春生
丁虹淋
刘凤军
Guo Changgang;Bao Guochang;Gao Zhiming;Li Chunsheng;Ding Honglin;Liu Fengjun(Department of Urology,Affiliated Hospital of Chifeng University,Inner Mongolia Chifeng 024000,China)
出处
《现代肿瘤医学》
CAS
2020年第13期2283-2286,共4页
Journal of Modern Oncology
关键词
2ΜM激光
整块切除
电切术
非肌层浸润性膀胱癌
2μm laser
en bloc resection
transurethral resection
non-muscle invasive bladder carcinoma
